Table 2.
Procedural characteristics of the study population
| Characteristics | All patients n = 795 |
|---|---|
| Time of procedure, minutes | 44.0 (35.0; 60.0) |
| Amount of CM for procedure, mL | 125 (105; 150) |
| Postdilatation | 98 (12.3%) |
| Self-expandable valve number (%) | 625 (78.6%) |
| Balloon-expandable valve number (%) | 170 (21.4%) |
| Device success | 732 (92.1%) |
| Concomitant PCI | 2 (0.3%) |
| Postprocedural variables | |
| Myocardial infarction, number (%) | 7 (0.9%) |
| Stroke, number (%) | 42 (5.3%) |
| Death within 24 hours, number (%) | 11 (1.4%) |
| New pacemaker implantation | 165 (20.7%) |
| Closure device failure | 76 (9.6%) |
| Life-threatening or major bleeding | 255 (32.1%) |
| Cardiac tamponade | 31 (3.9%) |
| AKI (any stage) | 156 (19.6%) |
| AKI Stage I, number (%) | 77 (9.7%) |
| AKI Stage II, number (%) | 18 (2.3%) |
| AKI Stage III, number (%) | 61 (7.7%) |
| Need for hemodialysis, number (%) | 63 (7.9%) |
| Hospitalization length of stay, days | 20 (15; 27) |
All values are given in median (interquartile range) or number (%) unless otherwise stated.
AKI, acute kidney injury; CM, contrast medium; PCI, percutaneous coronary intervention.